Bone morphogenetic proteins 2, 5, and 6 in combination stimulate osteoblasts but not osteoclasts in vitro

Journal of Orthopaedic Research

Volumn 28, Issue 11, 2010, Pages 1431-1439

  Wutzl, Arno ^a   Rauner, Martina ^a   Seemann, Rudolf ^a   Millesi, Werner ^b   Krepler, Petra ^a   Pietschmann, Peter ^a   Ewers, Rolf ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Krankenhaus Hietzing   (Austria)

Author keywords

BMP 2; BMP 5; BMP 6; Osteoblast; Osteoclast

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 5; BONE MORPHOGENETIC PROTEIN 6; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN;

ANIMAL; ARTICLE; BONE MINERALIZATION; CELL CULTURE; DRUG EFFECT; GENETICS; MOUSE; OSTEOBLAST; OSTEOCLAST; PHYSIOLOGY;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 5; BONE MORPHOGENETIC PROTEIN 6; BONE MORPHOGENETIC PROTEINS; CALCIFICATION, PHYSIOLOGIC; CELLS, CULTURED; MICE; OSTEOBLASTS; OSTEOCLASTS; OSTEOPROTEGERIN; RANK LIGAND;

EID: 77957944959     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.21144     Document Type: Article

References (40)

1. Olsen BR, Reginato AM, Wang W. 2000. Bone development.Annu Rev Cell Dev Biol 16:191-220.
2. Reddi AH. 1998. Role of morphogenetic proteins in skeletaltissue engineering and regeneration. Nat Biotechnol16:247-252.
3. Komori T, Yagi H, Nomura S, et al. 1997. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 30:755-764.
4. Yamaguchi A, Ishizuya T, Kintou N, et al. 1996. Effects ofBMP-2, BMP-4, and BMP-6 on osteoblastic differentiationof bone marrow-derived stromal cell lines, ST2 and MC3T3-G2/PA6. Biochem Biophys Res Commun 220:366-371.
5. Yamaguchi A, Katagiri T, Ikeda T, et al. 1991. Recombinanthuman bone morphogenetic protein-2 stimulates osteoblasticmaturation and inhibits myogenic differentiation in vitro.J Cell Biol 113:681-687.
6. Zou H, Wieser R, Massague J, et al. 1997. Distinct rolesof type I bone morphogenetic protein receptors in the formationand differentiation of cartilage. Genes Dev 1:2191- 2203.
7. Cheng H, Jiang W, Phillips FM, et al. 2003. Osteogenicactivity of the fourteen types of human bone morphogeneticproteins (BMPs). J Bone Joint Surg Am 85-A:1544- 1552.
8. Wutzl A, Brozek W, Lernbass I, et al. 2006. Bone morphogeneticproteins 5 and 6 stimulate osteoclast generation. JBiomed Mater Res A 77:75-83.
9. Arosarena OA, Puleo D. 2007. In vitro effects of combinedand sequential bone morphogenetic protein administration.Arch Facial Plast Surg 9:242-247.
10. Luu HH, Song WX, Luo X, et al. 2007. Distinct roles of bonemorphogenetic proteins in osteogenic differentiation of mesenchymalstem cells. J Orthop Res 25:665-677.
11. Hunziker EB. 1994. Mechanism of longitudinal bone growthand its regulation by growth plate chondrocytes.Microsc ResTech 28:505-519.
12. Baron RE. 1996. Anatomy and ultrastructure of bone. In: Favus MJ, editor. Primer on the metabolic bone diseases and disorders of mineral metabolism, 3rd ed. New York: Lippincot-Raven; p3-10.
13. Boden SD, Zdeblick TA, Sandhu HS, et al. 2000. The useof rhBMP-2 in interbody fusion cages. Definitive evidenceof osteoinduction in humans: A preliminary report. Spine25:376-381.
14. Sandhu H. 2004. Spinal fusion using bone morphogeneticproteins. Orthopedics 27:717-718.
15. Bishop GB, Einhorn TA. 2007. Current and future clinical applications of bone morphogenetic proteins in orthopaedic trauma surgery. Int Orthop 31:721-727.
16. Valentin-Opran A, Wozney J, Csimma C, et al. 2002. Clinicalevaluation of recombinant human bone morphogeneticprotein-2. Clin Orthop 395:110-120.
17. Jung RE, Glauser R, Scharer P, et al. 2003. Effect of rhBMP-2on guided bone regeneration in humans. Clin Oral ImplantsRes 14:556-568.
18. Warnke PH, Springer IN, Wiltfang J, et al. 2004. Growthand transplantation of a custom vascularised bone graft in aman. Lancet 364:766-770.
19. Govender S, Csimma C, Genant HK, et al. 2002. BMP-2Evaluation in Surgery for Tibial Trauma (BESTT) StudyGroup: Recombinant human bone morphogenetic protein-2for treatment of open tibial fractures: A prospective, controlled, randomized study of four hundred and fifty patients.J Bone Joint Surg Am 84-A:2123-2134.
20. Johnsson R, Stromqvist B, Aspenberg P. 2002. Randomizedradiostereometric study comparing osteogenic protein-1(BMP-7) and autograft bone in human noninstrumentedposterolateral lumbar fusion: 2002 Volvo Award in clinicalstudies. Spine 27:2654-2661.
21. Becker J, Kirsch A, Schwarz F, et al. 2006. Bone apposition totitanium implants biocoated with recombinant human bonemorphogenetic protein-2 (rhBMP-2). A pilot study in dogs.Clin Oral Investig 10:217-224.
22. Hou LT, Liu CM, Liu BY, et al. 2007. Tissue engineering boneformation in novel recombinant human bone morphogenicprotein 2-atelocollagen composite scaffolds. J Periodontol78:335-343.
23. Otsuka E, Notoya M, Hagiwara H. 2003. Treatment ofmyoblastic C2C12 cells with BMP-2 stimulates vitamin Dinducedformation of osteoclasts. Calcif Tissue Int 73:72- 77.
24. Einhorn TA, Lee CA. 2001. Bone regeneration: New findingsand potential clinical applications. J Am Acad Orthop Surg9:157-165.
25. Lacey DL, Timms E, Tan HL, et al. 1998. Osteoprotegerinligand is a cytokine that regulates osteoclast differentiationand activation. Cell 93:165-176.
26. Lieberman JR, Daluiski A, Einhorn TA. 2002. The role ofgrowth factors in the repair of bone. Biology and clinicalapplications. J Bone Joint Surg Am 84-A:1032-1044.
27. Yeh LC, Adamo ML, Olson MS, et al. 1997. Osteogenic protein-1 and insulin-like growth factor I synergistically stimulate rat osteoblastic cell differentiation and proliferation.Endocrinology 138:4181-4190.
28. Kanatani M, Sugimoto T, Nishiyama K, et al. 2000. Stimulatoryeffect of insulin-like growth factor binding protein-5 onmouse osteoclast formation and osteoclastic bone-resorbingactivity. J Bone Miner Res 15:902-910.
29. Hentunen TA, Lakkakorpi PT, Tuukkanen J, et al. 1995.Effects of recombinant human osteogenic protein-1 on thedifferentiation of osteoclast-like cells and bone resorption.Biochem Biophys Res Commun 209:433-443.
30. Yasuda H, Shima N, Nakagawa N, et al. 1998.Osteoclast differentiation factor is a ligand forosteoprotegerin/osteoclastogenesis-inhibitory factor and isidentical to TRANCE/RANKL. Proc Natl Acad Sci USA95:3597-3602.
31. Otsuka E, Notoya M, Hagiwara H. 2003. Treatment ofmyoblastic C2C12 cells with BMP-2 stimulates vitamin Dinducedformation of osteoclasts. Calcif Tissue Int 55:72-77.
32. Itoh K, Udagawa N, Katagiri T, et al. 2001. Bone morphogeneticprotein 2 stimulates osteoclast differentiation andsurvival supported by receptor activator of nuclear factorkappaBligand. Endocrinology 142:3656-3662.
33. Abe E, Yamamoto M, Taguchi Y, et al. 2000. Essentialrequirement of BMPs-2/4 for both osteoblast and osteoclastformation in murine bone marrow cultures from adult mice:Antagonism by noggin. J Bone Miner Res 15:663-673.
34. Yazawa M, Kishi K, Nakajima H, et al. 2003. Expression ofbone morphogenetic proteins during mandibular distractionosteogenesis in rabbits. J Oral Maxillofac Surg 61:587-592.
35. Arosarena OA, Collins WL. 2003. Defect repair in therat mandible with bone morphogenic protein 5 andprostaglandin E1. Arch Otolaryngol Head Neck Surg129:1125-1130.
36. Solloway MJ, Dudley AT, Bikoff EK, et al. 1998. Mice lackingBmp6 function. Dev Genet 22:321-339.
37. Ebisawa T, Tada K, Kitajima I, et al. 1999. Characterizationof bone morphogenetic protein-6 signalingpathways in osteoblast differentiation. J Cell Sci 112:3519- 3527.
38. Gruber R, Kandler B, Fuerst G, et al. 2004. Porcine sinusmucosa holds cells that respond to bone morphogeneticprotein (BMP)-6 and BMP-7 with increased osteogenic differentiationin vitro. Clin Oral Implants Res 15:575-580.
39. Jane JA, Jr., Dunford BA, Kron A, et al. 2002. Ectopicosteogenesis using adenoviral bone morphogenetic protein(BMP)-4 and BMP-6 gene transfer. Mol Ther 6:464-470.
40. Rubin J, Titus L, Nanes MS. 1992. cAMP promotion ofosteoclast-like cell development from mouse bone marrowcells requires a permissive action of 1, 25-(OH)2D3. J BoneMiner Res 7:611-617.